nevirapine has been researched along with Asialia in 1 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of this article is to present the clinical characteristics and management of an oral adverse effect stemming from the use of the antiretroviral medication Nevirapine (NVP)." | 1.35 | Oral adverse effects due to the use of Nevirapine. ( Fonseca, LM; Madureira, DF; Mesquita, RA; Moura, MD; Senna, MI, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moura, MD | 1 |
Senna, MI | 1 |
Madureira, DF | 1 |
Fonseca, LM | 1 |
Mesquita, RA | 1 |
1 other study available for nevirapine and Asialia
Article | Year |
---|---|
Oral adverse effects due to the use of Nevirapine.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Burning Mouth Syndrome; CD4 Lymphocyt | 2008 |